News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Foley Mark J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 122,143 shares
@ $0
Paid exercise price by delivering 48,064 shares
@ $18.91, valued at
$908.9k
|
|
| 08/04/2023 |
4
| Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Sold 26,279 shares
@ $22.5713, valued at
$593.2k
|
|
| 07/05/2023 |
4
| Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 1,000 shares
@ $15.606, valued at
$15.6k
Sold 26,279 shares
@ $24.9375, valued at
$655.3k
|
|
| 05/16/2023 |
4
| Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 175,649 shares
@ $0
Sold 70,447 shares
@ $34.5469, valued at
$2.4M
|
|
| 03/17/2023 |
4
| Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,341 shares
@ $30.65, valued at
$163.7k
|
|
| 03/09/2023 |
4
| Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 175,649 shares
@ $0
Sold 70,390 shares
@ $31.5863, valued at
$2.2M
|
|
| 01/04/2023 |
4
| Foley Mark J (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 2,948 shares
@ $0 |
|
| 01/03/2023 |
4
| Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 605 shares
@ $12.1805, valued at
$7.4k
|
|
| 10/14/2022 |
4
| Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 49,274 shares
@ $26.97, valued at
$1.3M
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Foley Mark J (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 2,486 shares
@ $0 |
|
| 11/29/2021 |
4
| Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Bought 40,000 shares
@ $12.8981, valued at
$515.9k
|
|
| 10/15/2021 |
4
| Foley Mark J (CEO & President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 42,096 shares
@ $23.08, valued at
$971.6k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2020 |
4
| Foley Mark J (CEO & President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 264,439 shares
@ $0
Granted 50,913 shares
@ $0
Paid exercise price by delivering 66,106 shares
@ $27.62, valued at
$1.8M
|
|
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Foley Mark J (Director) has filed a Form 4 on SI-BONE, Inc.|
Txns:
| Granted 8,797 shares
@ $0 |
|
| 06/05/2020 |
4
| Foley Mark J (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 3,900 shares
@ $0 |
|
| 01/24/2020 |
4
| Foley Mark J (CEO & President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 200,000 shares
@ $0 |
|
| 10/15/2019 |
4
| Foley Mark J (CEO & President) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 200,000 shares
@ $0
Granted 740,000 options to buy
@ $0 |
|
| 06/17/2019 |
4
| Foley Mark J (Director) has filed a Form 4 on SI-BONE, Inc.|
Txns:
| Granted 26,236 options to buy
@ $17.72, valued at
$464.9k
|
|
| 05/31/2019 |
4
| Foley Mark J (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 2,653 shares
@ $0 |
|
| 05/10/2019 |
4
| Foley Mark J (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 4,500 shares
@ $0
Granted 9,000 options to buy
@ $12.82, valued at
$115.4k
|
|
| 06/01/2018 |
4
| Foley Mark J (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 4,633 shares
@ $0 |
|
| 05/11/2018 |
4
| Foley Mark J (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 6,000 options to buy
@ $29.15, valued at
$174.9k
|
|
| 12/14/2017 |
4
| Foley Mark J (Director) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Granted 15,000 options to buy
@ $25.77, valued at
$386.6k
|
|
| 11/09/2017 |
4
| Foley Mark J (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Bought 19,500 shares
@ $26.9458, valued at
$525.4k
Bought 500 shares
@ $27.45, valued at
$13.7k
|
|
| 09/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|